- Epimmune Inc. Home Page [IA][Direct] -
Formerly known as Cytel Corporation, was founded in 1987 to develop therapeutic products for treatment of immunological diseases. The Company's core business is the development of vaccines to treat and prevent infectious diseases and cancer. Epimmune's business also includes a therapeutic anti-inflammatory program based on cell adhesion inhibitors and its Glytec business unit, encompassing proprietary manufacturing technology for the enzymatic synthesis of bioactive complex carbohydrates.
|